This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CIARALDI, T. P. Articles by OLEFSKY, J. M. Search for Related Content PubMed PubMed Citation Articles by CIARALDI, T. P. Articles by OLEFSKY, J. M.

Insulin Action Kinetics in Adipocytes from Obese and Noninsulin-Dependent Diabetes Mellitus Subjects: Identification of Multiple Cellular Defects in Glucose Transport^*

Division of Endocrinology and Metabolism, Department of Medicine, University of California School of Medicine La Jolla, California 92093; and the Veterans Administration Medical Center, Medical Research Service San Diego, California 92161

Address all correspondence and requests for reprints to: Theodore P. Ciaraldi, Ph.D., Veterans Administration Medical Center, Medical Research Service (V-111G), 3350 La Jolla Village Drive, San Diego, California 92161.

Recent results from in vivo studies have shown that the kinetics of insulin action are impaired in lean and obese noninsulin-dependent diabetes mellitus (NIDDM) subjects as well as in obese nondiabetic subjects. We have measured the onset and loss of insulin action on glucose transport in adipocytes obtained from obese nondiabetic and obese NIDDM subjects to determine the contributions of obesity and diabetes to these cellular defects in insulin action. Basal and maximally insulin-stimulated rates of 3-O-methylglucose transport in adipocytes from obese and obese NIDDM subjects were reduced to 50% of the values in cells from normal subjects (P < 0.05). The activation of glucose transport by insulin (4.3 nmol/L) was slower in cells from obese NIDDM patients. Half of the maximal insulin effect (A₅₀) was reached by 23.0 ± 5.0 min compared to 9.4 ± 1.1 min in normal cells (P < 0.05). Conversely, the deactivation of insulin-stimulated glucose transport upon removal of insulin was more rapid in adipocytes from the obese and obese NIDDM subjects. Half of the maximal insulin effect (D₅₀) was lost by 12.4 ± 1.7 min in obese NIDDM cells and by 8.9 ± 1.9 min in obese subjects compared to 25.3 ± 1.9 min in adipocytes from normal subjects (P < 0.01). In conclusion, 1) basal and insulin-stimulated rates of glucose transport are similarly reduced in adipocytes from obese and obese NIDDM subjects; and 2) adipocytes from obese and obese NIDDM subjects display defects in the kinetics of insulin action, slower activation and accelerated deactivation, that mirror the defects measured in vivo. Both impairments in the kinetics of insulin action may contribute to the insulin resistance in these subject groups. (J Clin Endocrinol Metab 72: 876–882, 1991)

^* This work was supported by funds from the Medical Research Service of the V.A., NIH Grants DK-33649 and DK-33651, NIH Training Grant DK-07494, V.A. Associate Investigators Award (to J.M.M.), and the V.A. Special Diagnostic and Treatment Unit.

Received August 14, 1990.

This article has been cited by other articles:

				J. P. Kirwan, A. Varastehpour, M. Jing, L. Presley, J. Shao, J. E. Friedman, and P. M. Catalano Reversal of Insulin Resistance Postpartum Is Linked to Enhanced Skeletal Muscle Insulin Signaling J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4678 - 4684. [Abstract] [Full Text] [PDF]

				K. A. Virtanen, P. Lonnroth, R. Parkkola, P. Peltoniemi, M. Asola, T. Viljanen, T. Tolvanen, J. Knuuti, T. Ronnemaa, R. Huupponen, et al. Glucose Uptake and Perfusion in Subcutaneous and Visceral Adipose Tissue during Insulin Stimulation in Nonobese and Obese Humans J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3902 - 3910. [Abstract] [Full Text] [PDF]

				T. P. Ciaraldi, A. J. Morales, M. G. Hickman, R. Odom-Ford, J. M. Olefsky, and S. S. C. Yen Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1421 - 1425. [Abstract] [Full Text] [PDF]